Dimitrios Tzachanis, MD

Beth Israel Deaconess Medical CenterBoston, Massachusetts - 02215 |
- CLINICAL TRIALS 3
- CONDITIONS13
- INTERVENTIONS5
- SINCE2005

Reduced Intensity Conditioning With Clofarabine Antithymocyte Globulin (ATG) Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant
June 2008 - June 2011

A Phase III Randomized Double Blind Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma
April 2010 - March 2013

Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma
April 2005 - September 2011
Lymphoma
Lymphoma, Non-Hodgkin
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Myelodysplastic Syndromes
Preleukemia
Hodgkin Disease
Placebo
Panobinostat
Clofarabine
Antithymocyte Globulin
Dendritic Cell Tumor Fusion



